HEADER CELL CYCLE 26-SEP-21 7PT5 TITLE CRYSTAL STRUCTURE OF THE CH DOMAIN OF HUMAN CEP44 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CENTROSOMAL PROTEIN OF 44 KDA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CEP44,HBV PRES1-TRANSACTIVATED PROTEIN 3,PS1TP3; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: AMINO ACID RESIDUES GAMDP ARE RESIDUES OF TEV PROTEASE COMPND 7 CLEAVAGE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CEP44, KIAA1712; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS CENTRIOLE, CENTROSOME, CELL CYCLE, MICROTUBULE-ASSOCIATED PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR I.ROSA E SILVA,M.VAN BREUGEL REVDAT 2 20-APR-22 7PT5 1 JRNL REVDAT 1 06-APR-22 7PT5 0 JRNL AUTH M.VAN BREUGEL,I.ROSA E SILVA,A.ANDREEVA JRNL TITL STRUCTURAL VALIDATION AND ASSESSMENT OF ALPHAFOLD2 JRNL TITL 2 PREDICTIONS FOR CENTROSOMAL AND CENTRIOLAR PROTEINS AND JRNL TITL 3 THEIR COMPLEXES. JRNL REF COMMUN BIOL V. 5 312 2022 JRNL REFN ESSN 2399-3642 JRNL PMID 35383272 JRNL DOI 10.1038/S42003-022-03269-0 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 7072 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.930 REMARK 3 FREE R VALUE TEST SET COUNT : 702 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.48 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1190 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.3350 REMARK 3 BIN FREE R VALUE SET COUNT : 147 REMARK 3 BIN FREE R VALUE : 0.4005 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 976 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 4 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 73.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 103.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.332 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 127 REMARK 3 ORIGIN FOR THE GROUP (A): 6.5878 24.0540 14.2669 REMARK 3 T TENSOR REMARK 3 T11: 0.8303 T22: 0.4509 REMARK 3 T33: 0.5864 T12: 0.0187 REMARK 3 T13: -0.1221 T23: 0.0383 REMARK 3 L TENSOR REMARK 3 L11: 8.3121 L22: 11.0864 REMARK 3 L33: 8.5445 L12: -1.0156 REMARK 3 L13: 0.7816 L23: -1.4379 REMARK 3 S TENSOR REMARK 3 S11: 0.0102 S12: -0.3594 S13: -0.2634 REMARK 3 S21: 1.6177 S22: 0.0728 S23: -0.5775 REMARK 3 S31: 0.0695 S32: 0.1816 S33: 0.4618 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.11 REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7PT5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1292118230. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97928 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7159 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 81.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 21.40 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: CRANK2 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 NL PROTEIN SOLUTION AND 100 NL OF REMARK 280 RESERVOIR SOLUTION WHICH WAS 0.1 M HEPES PH 7.3, 10% ISOPROPANOL, REMARK 280 10% PEG-4000. CRYSTALS WERE MOUNTED 0.1 M HEPES PH 7.5, 7.5% REMARK 280 ISOPROPANOL, 30% PEG-400., VAPOR DIFFUSION, TEMPERATURE 292.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 121.67950 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 16.97450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 16.97450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 60.83975 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 16.97450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 16.97450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 182.51925 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 16.97450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 16.97450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 60.83975 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 16.97450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 16.97450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 182.51925 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 121.67950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 ALA A -3 REMARK 465 MSE A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MSE A 1 REMARK 465 ALA A 2 REMARK 465 THR A 3 REMARK 465 LEU A 65 REMARK 465 ILE A 66 REMARK 465 ALA A 67 REMARK 465 LYS A 68 REMARK 465 LYS A 128 REMARK 465 ILE A 129 REMARK 465 PRO A 130 REMARK 465 SER A 131 REMARK 465 GLN A 132 REMARK 465 GLN A 133 REMARK 465 ARG A 134 REMARK 465 LYS A 135 REMARK 465 LYS A 136 REMARK 465 ILE A 137 REMARK 465 SER A 138 REMARK 465 SER A 139 REMARK 465 GLY A 140 DBREF 7PT5 A 1 140 UNP Q9C0F1 CEP44_HUMAN 1 140 SEQADV 7PT5 GLY A -4 UNP Q9C0F1 EXPRESSION TAG SEQADV 7PT5 ALA A -3 UNP Q9C0F1 EXPRESSION TAG SEQADV 7PT5 MSE A -2 UNP Q9C0F1 EXPRESSION TAG SEQADV 7PT5 ASP A -1 UNP Q9C0F1 EXPRESSION TAG SEQADV 7PT5 PRO A 0 UNP Q9C0F1 EXPRESSION TAG SEQRES 1 A 145 GLY ALA MSE ASP PRO MSE ALA THR GLY ASP LEU LYS ARG SEQRES 2 A 145 SER LEU ARG ASN LEU GLU GLN VAL LEU ARG LEU LEU ASN SEQRES 3 A 145 TYR PRO GLU GLU VAL ASP CYS VAL GLY LEU ILE LYS GLY SEQRES 4 A 145 ASP PRO ALA ALA SER LEU PRO ILE ILE SER TYR SER PHE SEQRES 5 A 145 THR SER TYR SER PRO TYR VAL THR GLU LEU ILE MSE GLU SEQRES 6 A 145 SER ASN VAL GLU LEU ILE ALA LYS ASN ASP LEU ARG PHE SEQRES 7 A 145 ILE ASP ALA VAL TYR LYS LEU LEU ARG ASP GLN PHE ASN SEQRES 8 A 145 TYR LYS PRO ILE LEU THR LYS LYS GLN PHE ILE GLN CYS SEQRES 9 A 145 GLY PHE ALA GLU TRP LYS ILE GLN ILE VAL CYS ASP ILE SEQRES 10 A 145 LEU ASN CYS VAL MSE LYS LYS HIS LYS GLU LEU SER SER SEQRES 11 A 145 LEU GLN LYS ILE PRO SER GLN GLN ARG LYS LYS ILE SER SEQRES 12 A 145 SER GLY MODRES 7PT5 MSE A 59 MET MODIFIED RESIDUE MODRES 7PT5 MSE A 117 MET MODIFIED RESIDUE HET MSE A 59 8 HET MSE A 117 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 2(C5 H11 N O2 SE) FORMUL 2 HOH *4(H2 O) HELIX 1 AA1 ASP A 5 ASN A 21 1 17 HELIX 2 AA2 ASP A 27 LYS A 33 1 7 HELIX 3 AA3 ASP A 35 SER A 49 1 15 HELIX 4 AA4 SER A 51 GLU A 60 1 10 HELIX 5 AA5 ASP A 70 GLN A 84 1 15 HELIX 6 AA6 THR A 92 GLN A 98 1 7 HELIX 7 AA7 PHE A 101 LEU A 126 1 26 LINK C ILE A 58 N MSE A 59 1555 1555 1.33 LINK C MSE A 59 N GLU A 60 1555 1555 1.33 LINK C VAL A 116 N MSE A 117 1555 1555 1.33 LINK C MSE A 117 N LYS A 118 1555 1555 1.33 CRYST1 33.949 33.949 243.359 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029456 0.000000 0.000000 0.00000 SCALE2 0.000000 0.029456 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004109 0.00000